165 related articles for article (PubMed ID: 18588659)
1. Targeting cardiovascular risk: early identification of insulin resistance.
Fortson J; Howe L; Harmon C; Sherrill WW
J Am Acad Nurse Pract; 2008 Jun; 20(6):319-25. PubMed ID: 18588659
[TBL] [Abstract][Full Text] [Related]
2. The metabolic syndrome: evolving evidence that thiazolidinediones provide rational therapy.
Wyne KL
Diabetes Obes Metab; 2006 Jul; 8(4):365-80. PubMed ID: 16776743
[TBL] [Abstract][Full Text] [Related]
3. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
Chapman MJ; Sposito AC
Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
[TBL] [Abstract][Full Text] [Related]
4. Central obesity and insulin resistance in the cardiometabolic syndrome: pathways to preclinical cardiovascular structure and function.
Klaus JR; Hurwitz BE; Llabre MM; Skyler JS; Goldberg RB; Marks JB; Bilsker MS; Schneiderman N
J Cardiometab Syndr; 2009; 4(2):63-71. PubMed ID: 19614791
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and insulin resistance: perioperative considerations.
Bagry HS; Raghavendran S; Carli F
Anesthesiology; 2008 Mar; 108(3):506-23. PubMed ID: 18292688
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome: at the crossroads of cardiorenal risk.
Natali A; Pucci G; Boldrini B; Schillaci G
J Nephrol; 2009; 22(1):29-38. PubMed ID: 19229816
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance syndrome: a potent culprit in cardiovascular disease.
Coulston AM; Peragallo-Dittko V
J Am Diet Assoc; 2004 Feb; 104(2):176-9. PubMed ID: 14760563
[No Abstract] [Full Text] [Related]
8. Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese.
Hsu LA; Ko YL; Wu S; Teng MS; Chou HH; Chang CJ; Chang PY
Metabolism; 2009 Jul; 58(7):983-8. PubMed ID: 19394054
[TBL] [Abstract][Full Text] [Related]
9. Obesity and the metabolic syndrome in the elderly--a mini-review.
Lechleitner M
Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance and polycystic ovary syndrome.
Galluzzo A; Amato MC; Giordano C
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):511-8. PubMed ID: 18657405
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance and endothelin: another pathway for renal injury in patients with the cardiometabolic syndrome?
Sarafidis PA; Lasaridis AN
J Cardiometab Syndr; 2008; 3(3):183-7. PubMed ID: 18983337
[TBL] [Abstract][Full Text] [Related]
12. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
Bethea SW; Nestler JE
Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
[TBL] [Abstract][Full Text] [Related]
13. The metabolic syndrome: definitions, prevalence and management.
Levesque J; Lamarche B
J Nutrigenet Nutrigenomics; 2008; 1(3):100-8. PubMed ID: 19776619
[TBL] [Abstract][Full Text] [Related]
14. Early insulin treatment to prevent cardiovascular disease in prediabetes and overt diabetes.
Roman G; Hancu N
Horm Metab Res; 2009 Feb; 41(2):116-22. PubMed ID: 19214921
[TBL] [Abstract][Full Text] [Related]
15. [Insulin, nitric oxide and the sympathetic nervous system: from crossroads to metabolic and cardiovascular homeostasis].
Sartori C; Thalmann S; Jayet PY; Duplain H; Vollenweider P; Scherrer U
Rev Med Suisse Romande; 2004 Oct; 124(10):635-8. PubMed ID: 15573509
[TBL] [Abstract][Full Text] [Related]
16. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
Nathanson D; Nyström T
Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk and insulin resistance in patients with obstructive sleep apnea.
Tkacova R; Dorkova Z; Molcanyiova A; Radikova Z; Klimes I; Tkac I
Med Sci Monit; 2008 Sep; 14(9):CR438-44. PubMed ID: 18758413
[TBL] [Abstract][Full Text] [Related]
18. Dyslipidemia in insulin resistance: clinical challenges and adipocentric therapeutic frontiers.
Toh SA; Rader DJ
Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):1007-22. PubMed ID: 18666851
[TBL] [Abstract][Full Text] [Related]
19. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
Campbell RK
J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance syndrome and glucose dysregulation in the elderly.
Mazza AD
Clin Geriatr Med; 2008 Aug; 24(3):437-54, vi. PubMed ID: 18672181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
